Research ArticleImmunotherapy

Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia

See allHide authors and affiliations

Science Translational Medicine  02 Sep 2015:
Vol. 7, Issue 303, pp. 303ra139
DOI: 10.1126/scitranslmed.aac5415

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article